DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease (PEPCADIII)
Paclitaxel-Eluting PTCA-Balloon in Combination With the CoroflexTM Blue Stent vs the Sirolimus Coated CypherTM Stent in the Treatment of Advanced Coronary Artery Disease
Sponsor: B.Braun Vascular Systems, Berlin, Germany
This PHASE1/PHASE2 trial investigates Coronary Artery Disease and is currently completed. B.Braun Vascular Systems, Berlin, Germany leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- B.Braun Vascular Systems, Berlin, Germany
- University Hospital, Saarland
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Arnhem, Netherlands , Bad Nauheim, Germany , Badalona, Spain , Berlin, Germany , Caen, France , Dortmund, Germany , Freiburg im Breisgau, Germany , Genk, Belgium , Hanover, Germany and 6 more locations